Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.24 USD | +0.52% | -2.05% | -17.53% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.53% | 3.11B | |
+5.52% | 32.88B | |
+16.74% | 7.84B | |
+23.16% | 3.95B | |
-20.33% | 1.38B | |
-30.65% | 1.21B | |
+7.73% | 933M | |
-33.44% | 911M | |
-26.60% | 829M | |
-18.63% | 728M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Earnings Flash (EVH) EVOLENT HEALTH Reports Q3 Loss $-0.03, vs. Street Est of $-0.03